These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 6400097)
61. Immunologic methods for the detection of carcinogen adducts in humans. Santella RM; Yang XY; Hsieh LL; Young TL; Lu XQ; Stefanidis M; Perera FP Basic Life Sci; 1990; 53():33-44. PubMed ID: 2282041 [No Abstract] [Full Text] [Related]
62. Improved immunocytochemical staining of carcinogen-DNA adducts by a capillary slot block system. Scherer E; Van Benthem J J Histochem Cytochem; 1990 Mar; 38(3):433-6. PubMed ID: 1689342 [TBL] [Abstract][Full Text] [Related]
63. Competitive enzyme immunoassay for human plasma fibronectin. Vuento M; Salonen E; Pasanen M; Stenman UH J Immunol Methods; 1981; 40(1):101-8. PubMed ID: 7009754 [TBL] [Abstract][Full Text] [Related]
65. Immunological detection of lesions in DNA. Leng M Biochimie; 1985; 67(3-4):309-15. PubMed ID: 3899185 [TBL] [Abstract][Full Text] [Related]
66. Antibodies to DNA alkylation adducts as analytical tools in chemical carcinogenesis. Wild CP Mutat Res; 1990; 233(1-2):219-33. PubMed ID: 2233803 [No Abstract] [Full Text] [Related]
67. New variants of enzyme immunoassay of antibodies to DNA. Babkina SS; Medyantseva EP; Budnikov HC; Tyshlek MP Anal Chem; 1996 Nov; 68(21):3827-31. PubMed ID: 8914484 [TBL] [Abstract][Full Text] [Related]
68. Enzyme-Linked Immunosorbent Assay of Fungal NADP-Glutamate Dehydrogenase. Martin F; Botton B; Msatef Y Plant Physiol; 1983 Jun; 72(2):398-401. PubMed ID: 16663014 [TBL] [Abstract][Full Text] [Related]
69. Antibodies specific for DNA components structurally modified by chemical carcinogens. Müller R; Rajewsky MF J Cancer Res Clin Oncol; 1981; 102(2):99-113. PubMed ID: 7040411 [No Abstract] [Full Text] [Related]
70. Production and characterization of monoclonal antibodies to N7-phenylguanine. Schell C; Verkoyen C; Krewet E; Müller G; Norpoth K J Cancer Res Clin Oncol; 1993; 119(4):221-6. PubMed ID: 8423197 [TBL] [Abstract][Full Text] [Related]
71. Immunological detection and quantification of carcinogen-modified DNA components. Müller R; Adamkiewicz J; Rajewsky MF IARC Sci Publ; 1982; (39):463-79. PubMed ID: 6759386 [TBL] [Abstract][Full Text] [Related]
73. Quantitation of carcinogen-DNA adducts by a standardized high-sensitive enzyme immunoassay. Kriek E; Welling M; van der Laken CJ IARC Sci Publ; 1984; (59):297-305. PubMed ID: 6400097 [TBL] [Abstract][Full Text] [Related]
74. Immunochemical quantitation of DNA adducts derived from the human bladder carcinogen 4-aminobiphenyl. Roberts DW; Benson RW; Groopman JD; Flammang TJ; Nagle WA; Moss AJ; Kadlubar FF Cancer Res; 1988 Nov; 48(22):6336-42. PubMed ID: 3180051 [TBL] [Abstract][Full Text] [Related]
75. Measurement of benzo(a)pyrene-DNA adducts by enzyme immunoassays and radioimmunoassay. Hsu IC; Poirier MC; Yuspa SH; Grunberger D; Weinstein IB; Yolken RH; Harris CC Cancer Res; 1981 Mar; 41(3):1091-5. PubMed ID: 7459852 [TBL] [Abstract][Full Text] [Related]
76. Binding efficiency of antibodies to DNA modified with aromatic amines and polycyclic aromatic hydrocarbons: implications for quantification of carcinogen-DNA adducts in vivo. Kriek E; Van Schooten FJ; Hillebrand MJ; Welling MC IARC Sci Publ; 1988; (89):201-7. PubMed ID: 3143670 [TBL] [Abstract][Full Text] [Related]